Clinical Trial Update: Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study [Phase 3]

View source ↗

Summary

This entry reports a Phase 3 trial evaluating rifaximin re-treatment for irritable bowel syndrome with diarrhea and notes that results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• XIFAXAN (rifaximin)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Irritable Bowel Syndrome With Diarrhea | Phase 3 | Status: COMPLETED | Results posted: 2015-07-08